An Open-Label Trial of Riluzole in Patients With Treatment-Resistant Major Depression - Zarate, Carlos A.; Payne, Jennifer L.; Quiroz, Jorge; Sporn, Jonathan; Denicoff, Kirk K.; Luckenbaugh, David; Charney, Dennis S.; Manji, Husseini K. (The American journal of psychiatry, 2004)
Keywords: Adolescent; Adult; Aged; Anticonvulsants - administration & dosage; Anticonvulsants - therapeutic use; Antidepressants; Biological and medical sciences; Depressive Disorder, Major - diagnosis; Depressive Disorder, Major - drug therapy; Drug Resistance; Drug therapy; Female; Humans; Male; Medical sciences; Mental depression; Middle Aged; Neuropharmacology; Pharmacology. Drug treatments; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease); Psychology. Psychoanalysis. Psychiatry; Psychopharmacology; Recurrence; Riluzole - administration & dosage; Riluzole - therapeutic use; Severity of Illness Index; Surveys and Questionnaires; Mood disorder; Human; Treatment resistance; Psychotropic; Toxicity; Benzothiazole; Treatment efficiency; Depression; Recurrent; Riluzole; Dose activity relation; Symptomatology; Chemotherapy; Treatment; Follow up study; Antidepressant agent; Evolution; Severity score; Comparative study